Cargando…

Visual Outcomes in Pediatric Patients with Peters Anomaly

PURPOSE: This study aimed to evaluate the visual outcomes of pediatric patients diagnosed with Peters anomaly (PA) in a tertiary eye care center. METHODS: This was a retrospective study undertaken at a single academic center. Clinical records of pediatric patients diagnosed with PA from 2000 to 2017...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouzdar-Jain, Samiksha, Ibrahim, Zena, Reitinger, Jeremy, Cao, Dingcai, Mocan, Mehmet C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219306/
https://www.ncbi.nlm.nih.gov/pubmed/34177260
http://dx.doi.org/10.2147/OPTH.S302299
_version_ 1783710898869764096
author Fouzdar-Jain, Samiksha
Ibrahim, Zena
Reitinger, Jeremy
Cao, Dingcai
Mocan, Mehmet C
author_facet Fouzdar-Jain, Samiksha
Ibrahim, Zena
Reitinger, Jeremy
Cao, Dingcai
Mocan, Mehmet C
author_sort Fouzdar-Jain, Samiksha
collection PubMed
description PURPOSE: This study aimed to evaluate the visual outcomes of pediatric patients diagnosed with Peters anomaly (PA) in a tertiary eye care center. METHODS: This was a retrospective study undertaken at a single academic center. Clinical records of pediatric patients diagnosed with PA from 2000 to 2017 were reviewed. Parameters recorded included visual acuity (VA), intraocular pressure (IOP), presence of glaucoma, and surgical procedures performed. The impact of PA type on final visual acuity levels was analyzed using generalized estimation equation models. RESULTS: Twenty-one eyes from 11 patients were analyzed. At the final visit, 9 eyes (42.8%) had a VA ≥20/200, while 12 (57%) had <20/200, ranging from 20/250 to no light perception. Of the study cohort, 15 (71.5%) eyes had type I, while six (28.5%) had type II PA. Glaucoma was present in 20 eyes (95%) at the final visit. One eye had dense central leucoma and microphthalmos where IOP could not be measured accurately. Seventeen eyes (81%) underwent at least one intraocular surgery, while the average number of surgeries per eye was 2.9 ± 2.5 (range=0– 9). The type of PA beta(se)=0.53 (0.41), p = 0.20] was not found to be a significant risk factor for worse VA. CONCLUSION: Severe visual impairment develops in the majority of patients with PA. The type of anomaly does not appear to be associated with a worse visual function in patients with PA. Glaucoma develops in a high percentage of this patient population, and thus close monitoring of IOP in this patient population is crucial.
format Online
Article
Text
id pubmed-8219306
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82193062021-06-24 Visual Outcomes in Pediatric Patients with Peters Anomaly Fouzdar-Jain, Samiksha Ibrahim, Zena Reitinger, Jeremy Cao, Dingcai Mocan, Mehmet C Clin Ophthalmol Original Research PURPOSE: This study aimed to evaluate the visual outcomes of pediatric patients diagnosed with Peters anomaly (PA) in a tertiary eye care center. METHODS: This was a retrospective study undertaken at a single academic center. Clinical records of pediatric patients diagnosed with PA from 2000 to 2017 were reviewed. Parameters recorded included visual acuity (VA), intraocular pressure (IOP), presence of glaucoma, and surgical procedures performed. The impact of PA type on final visual acuity levels was analyzed using generalized estimation equation models. RESULTS: Twenty-one eyes from 11 patients were analyzed. At the final visit, 9 eyes (42.8%) had a VA ≥20/200, while 12 (57%) had <20/200, ranging from 20/250 to no light perception. Of the study cohort, 15 (71.5%) eyes had type I, while six (28.5%) had type II PA. Glaucoma was present in 20 eyes (95%) at the final visit. One eye had dense central leucoma and microphthalmos where IOP could not be measured accurately. Seventeen eyes (81%) underwent at least one intraocular surgery, while the average number of surgeries per eye was 2.9 ± 2.5 (range=0– 9). The type of PA beta(se)=0.53 (0.41), p = 0.20] was not found to be a significant risk factor for worse VA. CONCLUSION: Severe visual impairment develops in the majority of patients with PA. The type of anomaly does not appear to be associated with a worse visual function in patients with PA. Glaucoma develops in a high percentage of this patient population, and thus close monitoring of IOP in this patient population is crucial. Dove 2021-06-18 /pmc/articles/PMC8219306/ /pubmed/34177260 http://dx.doi.org/10.2147/OPTH.S302299 Text en © 2021 Fouzdar-Jain et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Fouzdar-Jain, Samiksha
Ibrahim, Zena
Reitinger, Jeremy
Cao, Dingcai
Mocan, Mehmet C
Visual Outcomes in Pediatric Patients with Peters Anomaly
title Visual Outcomes in Pediatric Patients with Peters Anomaly
title_full Visual Outcomes in Pediatric Patients with Peters Anomaly
title_fullStr Visual Outcomes in Pediatric Patients with Peters Anomaly
title_full_unstemmed Visual Outcomes in Pediatric Patients with Peters Anomaly
title_short Visual Outcomes in Pediatric Patients with Peters Anomaly
title_sort visual outcomes in pediatric patients with peters anomaly
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219306/
https://www.ncbi.nlm.nih.gov/pubmed/34177260
http://dx.doi.org/10.2147/OPTH.S302299
work_keys_str_mv AT fouzdarjainsamiksha visualoutcomesinpediatricpatientswithpetersanomaly
AT ibrahimzena visualoutcomesinpediatricpatientswithpetersanomaly
AT reitingerjeremy visualoutcomesinpediatricpatientswithpetersanomaly
AT caodingcai visualoutcomesinpediatricpatientswithpetersanomaly
AT mocanmehmetc visualoutcomesinpediatricpatientswithpetersanomaly